Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Lincoln Pharmaceuticals has informed that the Company has received the enclosed intimation letter from its RTA –Link Intime India, regarding the duplicate share certificate of the Company that have been issued, the details of which are enclosed. Pursuant to the SEBI Circular No. SEBI/HO/MIRSD/MIRSD_RTAMB/P/2022/8 dated January 25, 2022, a letter of confirmation will be issued to the securities holder/claimant upon completion of necessary procedures regarding duplicate share certificates.
The above information is a part of company’s filings submitted to BSE.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1515.00 |
Dr. Reddys Lab | 6080.25 |
Cipla | 1565.50 |
Zydus Lifesciences | 1110.95 |
Lupin | 1601.00 |
View more.. |